Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan

SHU-YUNG LINYang C.-Y.BIN-CHI LIAOCHAO-CHI HOWEI-YU LIAOKUAN-YU CHENTZU-HSIU TSAICHIA-LIN HSUHsu W.-H.KANG-YI SUYIH-LEONG CHANGJIH-HSIANG LEECHIA-CHI LINJIN-YUAN SHIHCHIH-HSIN YANGCHONG-JEN YU2022-09-152022-09-1520181837-9664https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046090932&doi=10.7150%2fjca.24985&partnerID=40&md5=e0e7e61e194f8311db581474210a0ad7https://scholars.lib.ntu.edu.tw/handle/123456789/620275[SDGs]SDG3Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwanjournal article10.7150/jca.249852-s2.0-85046090932